$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
When is the best time to take venetoclax/venetoclax?
2026-02-01 22:25:32
Check Details
Venetoclax/Venetoclax Tablets Benefits and Side Effects
2026-02-01 22:25:32
Check Details
What to do if lapatinib is resistant
2026-02-01 22:25:32
Check Details
Lapatinib Instructions for Use
2026-02-01 22:25:32
Check Details
Lapatinib resistance mechanism
2026-02-01 22:25:32
Check Details
The simplest treatment for discontinuation of pitobrutinib
2026-02-01 22:25:32
Check Details
Pitobrutinib Chinese instructions
2026-02-01 22:25:32
Check Details
Indications for Pitobrutinib
2026-02-01 22:25:32
Check Details
The efficacy and mechanism of tucatinib
2026-02-01 22:25:32
Check Details
Tucatinib usage and dosage guidance
2026-02-01 22:25:32
Check Details
What are the advantages of Tucatinib in the treatment of colorectal cancer?
2026-02-01 22:25:32
Check Details
What are the side effects of Tucatinib?
2026-02-01 22:25:32
Check Details
1
2
...
1183
1184
1185
1186
1187
1188
1189
...
10224
10225
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
2
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
3
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
4
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
5
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
6
Ponatinib: A Third-Generation TKI Targeting BCR::ABL1 to Overcome Leukemia Drug Resistance
7
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
8
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
9
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
10
Eltrombopag Administration Timing and Alternative Therapy Guide
11
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
12
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use